Company-wide revenue
Reported revenue in 2021 ¥51.61B Reported revenue in 2025 ¥69.51B
- growth amount
- +¥17.9B
- growth annualized
- +7.7%
- growth total
- +34.7%
Japanese company profile · 2796
Pharmarise Holdings Corporation
In its FY2025 public filing, Pharmarise Holdings Corporation reports Pharmacy, Product Sales Business, Medical records storage and management, Medical malls. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: ファーマライズホールディングス株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
Pharmarise Holdings Corporation's largest reported business by revenue in FY2025 was Pharmacy.
The business with the highest reported segment profit in FY2025 was Pharmacy.
FY2025 · fiscal year ended May 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Pharmacy | ¥59.33B ↗ | 85.4% | ¥1.39B ↗ |
| Product Sales Business | ¥8.04B ↗ | 11.6% | −¥83M ↗ |
| Medical records storage and management | ¥647M ↗ | 0.9% | ¥100M ↗ |
| Medical malls | ¥505M ↗ | 0.7% | ¥87M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended May 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Pharmacy
- 調剤薬局事業
- Product Sales Business
- 物販事業
- Medical records storage and management
- 医学資料保管・管理事業
- Medical malls
- 医療モール経営事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Pharmacy
- 調剤薬局事業
- Product Sales Business
- 物販事業
- Medical records storage and management
- 医学資料保管・管理事業
- Medical malls
- 医療モール経営事業
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Pharmacy | ¥42.04B | ¥42.33B | ¥44.18B | ¥52.62B | ¥59.33B |
| Product Sales Business | ¥7.6B | ¥7.77B | ¥8.28B | ¥8.7B | ¥8.04B |
| Medical records storage and management | ¥699M | ¥646M | ¥664M | ¥609M | ¥647M |
| Medical malls | ¥503M | ¥505M | ¥506M | ¥511M | ¥505M |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Pharmacy
Reported revenue in 2021 ¥42.04B Reported revenue in 2025 ¥59.33B
- growth amount
- +¥17.29B
- growth annualized
- +9.0%
- growth total
- +41.1%
View original filing
Product Sales Business
Reported revenue in 2021 ¥7.6B Reported revenue in 2024 ¥8.7B
- growth amount
- +¥1.09B
- growth annualized
- +4.6%
- growth total
- +14.4%
View original filing
Medical malls
Reported revenue in 2021 ¥503M Reported revenue in 2024 ¥511M
- growth amount
- +¥8M
- growth annualized
- +0.5%
- growth total
- +1.6%
View original filing
Medical records storage and management
Reported profit margin in 2022 +12.5%
Reported profit margin in 2025 +15.5%
- growth margin points
- +2.9
View original filing
Product Sales Business
Reported profit margin in 2022 -2.6%
Reported profit margin in 2025 -1.0%
- growth margin points
- +1.5
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended May 2026
The source document may be in Japanese.
Filing ID: S100YXWI
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.